Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 260 Records) |
| Query Trace: CDK4[original query] |
|---|
| Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 9 167 115479. Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, Bianca Posocco, Serena Corsetti, Michele Bartoletti, Sara Gagno, Marco Orleni, Elena De Mattia, Massimo Baraldo, Erika Cecchin, Fabio Puglisi, Giuseppe Toffoli, Rossana Ronca |
| Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting. Cancer reports (Hoboken, N.J.) 2023 12 e1966. R Gencheva, M Petrova, P Kraleva, S Hadjidekova, M Radanova, N Conev, D Stoyanov, J Arabadjiev, E Tazimova, S Bachurska, M Eneva, M Tsvetkova, G Zhbantov, T Karanikolova, D Manov, A Ivanova, M Taushanova-Hadjieva, R Staneva, E Dimitrova, I Don |
| Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients. The oncologist 2023 11 . Jiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, Laura Min Xuan Chai, Mei-Hsuan Lee, Chun-Yu Liu, Yi-Fang Tsai, Chi-Cheng Huang, Ling-Ming Tseng, Cheng-Chih Hsu, Ta-Chung Ch |
| A Phase I Study of the CDK4/6 Inhibitor, Palbociclib in Combination with Cetuximab and Radiotherapy (IMRT) for Locally Advanced Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 . Nuttapong Ngamphaiboon, Poompis Pattaranutaporn, Somthawin Lukerak, Teerada Siripoon, Artit Jinawath, Lalida Arsa, Prapimporn Ch Shantavasinkul, Naphat Taonam, Narumol Trachu, Natini Jinawath, Arpakorn Kositwattanarerk, Thiparom Sananmuang, Chuleeporn Jiarpinitn |
| Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients. International journal of molecular sciences 2023 11 24 (21): . Bianca Costa Soares de Sá, Luciana Facure Moredo, Giovana Tardin Torrezan, Felipe Fidalgo, Érica Sara Souza de Araújo, Maria Nirvana Formiga, João Pereira Duprat, Dirce Maria Carra |
| Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data. International journal of clinical oncology 2024 9 . Tokimasa Hida, Junji Kato, Masashi Idogawa, Takashi Tokino, Hisashi Uha |
| Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung cancer (Amsterdam, Netherlands) 2024 9 196 107935. Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh S Ramalingam, Joanne Xiu, Phillip Walker, Matthew J Oberley, Patrick C Ma, Stephen V L |
| PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2- breast cancer. Cancer medicine 2024 9 13 (17): e70101. Eduardo Terán, Rebeca Lozano, César A Rodríguez, Mar Abad, Luis Figuero, José Antonio Muñoz, Belén Cigarral, Aline Rodrígues, Magdalena Sancho, M Asunción Gómez, Daniel Morchón, Juan Carlos Montero, José María Sayagués, M Dolores Ludeña, Emilio Fonse |
| Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohort. British journal of cancer 2024 9 . Deepika Prasad, Elisa Baldelli, Edik M Blais, Justin Davis, Emna El Gazzah, Claudius Mueller, Alison Gomeiz, Aisha Ibrahim, Avani Vinayak Newrekar, Brian A Corgiat, Rick Dunetz, Emanuel F Petricoin Iii, Qi Wei, Mariaelena Pierob |
| Clinicopathological characteristics and genetic features of young and senior Ewing sarcoma patients. Diagnostic pathology 2024 9 19 (1): 124. Jiali Li, Yuan |
| Prevalence of CDKN2A, CDK4, POT1, BAP1, MITF, ATM, and TERT Pathogenic Variants in a Single-Center Retrospective Series of Patients With Melanoma and Personal or Family History Suggestive of Genetic Predisposition. Dermatology practical & conceptual 2024 8 14 (3): . Giada Ferrara, Salvatore Paiella, Giulio Settanni, Melissa Frizziero, Paolo Rosina, Valeria Viasso |
| Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer. International journal of cancer 2024 8 . Charlotte K Kindt, Carla L Alves, Sidse Ehmsen, Amalie Kragh, Thomas Reinert, Marianne Vogsen, Annette R Kodahl, Jeanette D Rønlev, Dilan Ardik, Anna L Sørensen, Kirstine Evald, Mia L Clemmensen, Johan Staaf, Henrik J Ditz |
| Elacestrant in ER+, HER2- MBC with ESR1-mutated tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy Plus CDK4/6 Inhibitor and in Clinical Subgroups. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 8 . Aditya Bardia, Javier Cortes, Francois-Clement Bidard, Patrick Neven, Jose Garcia-Saenz, Philippe Aftimos, Joyce O'Shaughnessy, Janice Lu, Giulia Tonini, Simona Scartoni, Alessandro Paoli, Monica Binaschi, Tomer Wasserman, Virginia Kaklama |
| Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors. British journal of cancer 2024 8 . Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, Constance Lamy, Magali Lacroix-Triki, Thomas Bachelot, Thomas Filleron, Ludovic Lacroix, Alicia Tran-Dien, Pascal Jézéquel, Marjorie Mauduit, Janice Barros Monteiro, Marta Jimenez, Stefan Michiels, Valery Attignon, Isabelle Soubeyran, Keltouma Driouch, Nicolas Servant, Christophe Le Tourneau, Maud Kamal, Fabrice André, Ivan Bièc |
| A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients. Neuro-oncology 2024 7 . Mary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, Jayne Vogelzang, Cecilia Sousa, Will Pisano, Jack Geduldig, Varun Bhave, Joseph Driver, Pei-Chi Kao, Alana McGovern, Clement Ma, Ashley S Margol, Kristina Cole, Amy Smith, Stewart Goldman, Kristiyana Kaneva, Ai Lien Truong, Kellie J Nazemi, Matthew D Wood, Karen D Wright, Wendy B London, Katherine E Warren, Patrick Y Wen, Wenya Linda Bi, Sanda Alexandrescu, David A Reardon, Keith L Ligon, Kee Kiat Y |
| Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast cancer research : BCR 2024 7 26 (1): 118. Arun Kadamkulam Syriac, Nitish Singh Nandu, Allison Clark, Mehrad Tavallai, Dexter X Jin, Ethan Sokol, Kimberly McGregor, Jeffrey S Ross, Natalie Danziger, Jose Pablo Leo |
| Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis. Frontiers in oncology 2024 6 14 1408664. Marcin Kubeczko, Anna Polakiewicz-Gilowska, Katarzyna ?widerska, Aleksandra Le?niak, Marta Mianowska-Malec, Barbarba ?anoszka, Konstanty Chomik, Barbara Grandys, Natalya Lisovska, Barbara Bobek-Billewicz, Ewa Chmielik, Micha? Jarz |
| Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 5 . Xusheng Tang, Xiaojuan Hu, Lin Yuan, Hainan Yang, Yunfen Luo, Da Liu, Qingjun Hu, Changguo Shan, Tao Lin, Linbo Cai, Zhaoming Zhou, Xin Jin, Ming Lei, Weiping Ho |
| APOBEC3 mutagenesis drives therapy resistance in breast cancer. bioRxiv : the preprint server for biology 2024 5 . Avantika Gupta, Andrea Gazzo, Pier Selenica, Anton Safonov, Fresia Pareja, Edaise M da Silva, David N Brown, Yingjie Zhu, Juber Patel, Juan Blanco-Heredia, Bojana Stefanovska, Michael A Carpenter, Xin Pei, Denise Frosina, Achim A Jungbluth, Marc Ladanyi, Giuseppe Curigliano, Britta Weigelt, Nadeem Riaz, Simon N Powell, Pedram Razavi, Reuben S Harris, Jorge S Reis-Filho, Antonio Marra, Sarat Chandarlapa |
| Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort. Oral oncology 2024 4 152 106807. Norihisa Ichimura, Yusuke Urata, Takeru Kobayashi, Hideharu Hi |
| Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer. Signal transduction and targeted therapy 2024 12 9 (1): 345. Zongbi Yi, Kaixiang Feng, Dan Lv, Yanfang Guan, Youcheng Shao, Fei Ma, Binghe |
| Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. The Lancet. Oncology 2024 12 25 (12): e629-e638. Hope S Rugo, Florence Lerebours, Eva Ciruelos, Pamela Drullinsky, Manuel Ruiz-Borrego, Patrick Neven, Yeon Hee Park, Aleix Prat, Thomas Bachelot, Dejan Juric, Nicholas Turner, Nickolas Sophos, Juan Pablo Zarate, Christina Arce, Yu-Ming Shen, Stuart Turner, Hemanth Kanakamedala, Wei-Chun Hsu, Stephen Ch |
| Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses. International journal of clinical oncology 2024 12 . Hidetatsu Outani, Masachika Ikegami, Yoshinori Imura, Sho Nakai, Haruna Takami, Yuki Kotani, Akitomo Inoue, Seiji Oka |
| Analysis of cancer multigene panel testing for osteosarcoma in pediatric and adults using the center for cancer genomics and advanced therapeutics database in Japan. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2024 11 . Yoshiyuki Suehara, Rina Kitada, Satoshi Kamio, Koichi Ogura, Shintaro Iwata, Eisuke Kobayashi, Akira Kawai, Shinji Khosa |
| CDK4 gene copy number increase and concurrent genetic changes in acral melanoma of a Chinese cohort. Pathology 2024 10 . Leyuan Yang, Yan Liu, Ruiping Guo, Juan Du, Lingchao Liu, Xiaolong Liu, Jianfang Zhao, Fang Shi, Xin Zhang, Jing |
| A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines 2024 10 12 (10): . Alessandra Virga, Caterina Gianni, Michela Palleschi, Davide Angeli, Filippo Merloni, Roberta Maltoni, Paola Ulivi, Giovanni Martinelli, Ugo De Giorgi, Sara Bravacci |
| Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123). Journal of cancer research and clinical oncology 2024 10 150 (10): 438. David Witte, Ina Pretzell, Timm M Reissig, Alexander Stein, Janna-Lisa Velthaus, Annabel Alig, Hanibal Bohnenberger, Maren Knödler, Annika Kurreck, Sabrina Sulzer, Georg Beyer, Klara Dorman, Tabea Fröhlich, Stefanie Hegenberg, Celine Lugnier, Anna Saborowski, Arndt Vogel, Sebastian Lange, Maximilian Reichert, Franziska Flade, Lioba Klaas, Kirsten Utpatel, Heiko Becker, Annalen Bleckmann, Klaus Wethmar, Anke Reinacher-Schick, Christoph Benedikt Westphal |
| TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
| FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
| Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications. ESMO open 2025 1 10 (1): 104097. C Park, R Kim, J M Bae, T Lee, S Song, Y Kwak, K B Lee, J Youk, B Keam, T M Kim, D-W Kim, J-I Kim, J Choi, M K |
- Page last reviewed:Feb 1, 2024
- Content source: